Clinical Trial Update: Peginterferon Alpha-2b And Ribavirin to Treat Hepatitis C in HIV-Infected Patients [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating peginterferon alfa-2b plus ribavirin for treating hepatitis C in HIV-infected patients is completed, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis C

Drugs mentioned

• Peginterferon alpha-2b (pegylated interferon alfa-2b)
• Ribavirin (ribavirin)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Hepatitis C, HIV Infections | Phase 2 | Status: COMPLETED | Results posted: 2014-10-01